Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
The FDA approved Eli Lilly's Zepbound as the first drug for obesity-linked moderate-to-severe sleep apnea, potentially transforming treatment options for 80 million Americans.
health.wusf.usf.edu7h
FDA approves weight loss drug Zepbound to treat obstructive sleep apnea
The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.
FDA approves weight-loss drug Zepbound to treat sleep apnea
Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for ...
Newser on MSN10h
Weight-Loss Drug Receives Approval as Apnea Treatment
The FDA has granted approval for its first medication for certain patients with sleep apnea—the weight-loss drug Zepbound.
abc1312h
FDA approves Eli Lilly's obesity medication for obstructive sleep apnea
The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.
Eli Lilly to test weight loss drug Zepbound to treat addiction
Weight loss injections have become a popular choice to help people curb their appetite, but can they curb addiction, as well?
The Hill16h
FDA approves weight-loss drug to treat sleep apnea
On Friday, the federal agency green-lighted Eli Lilly’s Zepbound drug for the use, approving a prescription medicine suited for adults suffering from moderate to severe obstructive sleep apnea (OSA) ...